Ras proteins (H-, N-, K4A-, and K4B) are associated with cellular resistance to ionizing radiation (IR) and, consequently, may provide a potential target for radiosensitization strategies in cancer treatment. Several approaches have been used to compromise Ras activity and enhance IR-induced cell killing; however, these techniques either target proteins in addition to Ras or only target one member of the Ras family. In this study, I have used an adenovirus (AV1Y28) that expresses a single-chain antibody fragment directed against Ras proteins to investigate the mechanism(s) responsible for Ras-mediated radiation resistance. AV1Y28 enhanced the radiosensitivity of a number of human tumor cell lines without affecting the radiosensitivity of no...
Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by ...
Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras wa...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
Ras proteins (H-, N-, K4A-, and K4B) are associated with cellular resistance to ionizing radiation (...
Transformation with ras oncogenes results in increased radiation sur vival in many but not all cells...
BACKGROUND AND PURPOSE: Ras has been identified as a significant contributor to radiation resistance...
Oncogenic activation of Ras renders cancer cells resistant to ionizing radiation (IR), but the mecha...
Oncogenic activation of Ras renders cancer cells resistant to ionizing radiation (IR), but the mecha...
The critical pathways determining the resistance of tumor cells to ionizing radiation are poorly def...
Local recurrence after a definitive course of radiation therapy remains a significant clinical probl...
Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosi...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras wa...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
Ras activation promotes the survival of tumor cells after DNA damage. To reverse this survival advan...
Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by ...
Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras wa...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
Ras proteins (H-, N-, K4A-, and K4B) are associated with cellular resistance to ionizing radiation (...
Transformation with ras oncogenes results in increased radiation sur vival in many but not all cells...
BACKGROUND AND PURPOSE: Ras has been identified as a significant contributor to radiation resistance...
Oncogenic activation of Ras renders cancer cells resistant to ionizing radiation (IR), but the mecha...
Oncogenic activation of Ras renders cancer cells resistant to ionizing radiation (IR), but the mecha...
The critical pathways determining the resistance of tumor cells to ionizing radiation are poorly def...
Local recurrence after a definitive course of radiation therapy remains a significant clinical probl...
Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosi...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras wa...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
Ras activation promotes the survival of tumor cells after DNA damage. To reverse this survival advan...
Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by ...
Most cancer cells show resistance to ionizing radiation (IR)-induced cell death. Recently, Ki-Ras wa...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...